The delivery of program medicines is described in detail in Annex 1a to the ToR.

Sorafenibum - a drug used in the drug program described in detail in Annex 1a to the ToR.

Wismodegib - a drug used in drug programs described in detail in Annex 1a to the ToR.

Transtuzumab - a drug used in drug programs described in detail in Annex 1a to the ToR.

Transtuzumab (Kanjinti) - a drug used in drug programs described in detail in Annex 1a to the ToR.

Trabectedinum - a drug used in drug programs described in detail in Annex 1a to the ToR.

Brentuximabum - a drug used in drug programs, described in detail in Annex 1a to the ToR.

Palbociclibum - a drug used in drug programs described in detail in Annex 1a to the ToR.

Ribociclibum - a drug used in drug programs described in detail in Annex 1a to the ToR.

Trametinibum - a drug used in drug programs described in detail in Annex 1a to the ToR.

Sunitinibum - a drug used in drug programs, described in detail in Annex 1a to the ToR.

Dabrafenibum - a drug used in the drug program described in detail in Annex 1a to the ToR.

Lapatinibate - a drug used in the drug program described in detail in Annex 1a to the ToR.

Enzalutamidum - a drug used in drug programs, described in detail in Annex 1a to the ToR.

Abiraterone acetate - a drug used in drug programs described in detail in Annex 1a to the ToR.

Vemurafenib - a drug used in drug programs described in detail in Annex 1a to the ToR.

Kobimetinib - a drug used in drug programs, described in detail in Annex 1a to the ToR.